Improving Outcomes in Bipolar Disorder Through Community Pharmacist Interventions
This activity is supported by an educational grant from Sunovion Pharmaceuticals, Inc.
Megan Maroney, PharmD, BCPP
Clinical Assistant Professor
Department of Pharmacy Practice and Administration
Ernest Mario School of Pharmacy
Rutgers, the State University of New Jersey
Clinical Psychiatric Pharmacist
Monmouth Medical Center
Long Branch, New Jersey
Bipolar disorder affects approximately 60 million people worldwide and ranks as the 12th leading cause of disability globally. This continuing education activity is designed to discuss the features and impact of bipolar disorder, summarize the treatment landscape and pipeline activity for the disease, and describe effective counseling strategies that pharmacists can employ.
After completing this continuing education program, the participant will be able to:
- Discuss the disabling features of bipolar disorder and its significant impact on patients and society.
- Summarize the expansive treatment landscape for bipolar disorder and the role of emerging agents.
- Describe effective counseling strategies that pharmacists can employ for patients with bipolar disorder.
Type of activity:
March 6, 2015
March 6, 2017
Estimated time to complete activity:
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-15-012-H01-P. The activity is available for CE credit through March 6, 2017.